A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer
-
Published:2024-06
Issue:6
Volume:9
Page:103446
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Alonso-Gordoa T.ORCID,
Goodman M.ORCID,
Vulsteke C.ORCID,
Roubaud G.,
Zhang J.,
Parikh M.,
Piulats J.M.,
Azaro A.,
James G.D.,
Cavazzina R.,
Gangl E.T.,
Thompson J.,
Pouliot G.,
Kumar R.,
Sweeney C.ORCID